<DOC>
	<DOC>NCT02391584</DOC>
	<brief_summary>Study to assess the safety and efficacy of the XprESS device for transnasal Eustachian tube dilation.</brief_summary>
	<brief_title>XprESS Eustachian Tube Dilation Study</brief_title>
	<detailed_description>Prospective, multicenter, randomized controlled trial comparing balloon dilation of the Eustachian tube to continued medical management for treatment of persistent Eustachian tube dysfunction.</detailed_description>
	<criteria>â‰¥18 years old Have been diagnosed with symptoms of chronic Eustachian tube dysfunction for no less than 12 months prior to enrollment Have record of failed medical management for Eustachian tube dysfunction Have evidence of internal carotid artery dehiscence Be pregnant at the time of enrollment Be currently participating in other drug or device studies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>